• 11/10/2024

GSK Lifts Outlook After Sales Boost

Wall Street Journal

GSK said its fourth-quarter sales topped £8 billion, thanks to its best-selling shingles vaccine, and raised its guidance for 2024.

https://www.wsj.com/articles/gsk-sales-rose-on-shingles-vaccine-growth-rsv-drug-launch-1c28216c